Opioids Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Seizures may occur with overdoses of which of the following opioids: A Meperidine B Methadone C Tramadol D Oxycodone E Both Meperidine and Tramadol

A

Normeperidine, a metabolite of meperidine, and Tramadol both may cause seizures in overdose or withdrawal. They are both contraindicated with MAOs and may lead to serotonin syndrome. (WF): syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following opioids does NOT have an active metabolite: A Buprenorphine B Methadone C Morphine D Heroin E Oxycodone

A

Buprenorphine has norbuprenorphine, morphine has M3G and M6G, Heroin has 6MAM, Oxycodone has small amounts of oxymorphone. Methadone has no active metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A patient on 120mg of methadone complains of lightheadedness and a syncopal episode. His EKG reveals a QTc of 550msec. All the following are FALSE except: A Buprenorphine prolongs the QTc interval at usual clinical doses B QTc intervals above 500msec predispose to Torsades de Pointe C Potassium levels should be checked because Hyperkalemia prolongs the QTc interval. D Medications which induce CYP3A4 and 2D6 will increase the QTC interval in a methadone maintained patient. E Routine EKG screening of all methadone maintained patients has been shown to decrease morbidity and mortality.

A

QTc intervals above 500msec predispose to Torsades de Pointe. Buprenorphine does not significantly increase the QTc interval. Hypokalemia prolongs the QTc interval. Inducers of the 3A4 and 2D6 will decrease methadone levels, and thereby decrease not increase the QTC interval. Routine EKG screening of all methadone maintained patients has not been validated. It is a topic of controversy, but evidence of decrease morbidity and mortality is not available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following statement concerning heroin is true? A In 1924, the US Congress banned heroin’s sale, importation or manufacture. (Correct Answer) B When injected, heroin (diacetylmorphine) rapidly passes directly through the blood brain barrier then directly binds to the mu opioid receptors resulting in the drug’s euphoric effects. (Your Answer) C Metabolites of heroin include 6-monoacetylmorphine (6-MAM), morphine, morphine-3-glucuronide and codeine. D “Golden Crescent” is a term related to heroin-induced euphoria. E Symptoms of heroin withdrawal may include sweating, malaise, anxiety, depression and priapism and usually begin 36 to 54 hours after discontinuing the drug.

A

In 1924, the US Congress banned heroin’s sale, importation and manufacture. In 1925, the Health Committee of the League of Nations banned diacetylmorphine, although it took more than three years for this to be implemented. Heroin is a prodrug; therefore, after crossing the blood-brain barrier, it is then deacetylated variously into the inactive 3-monoacetylmorphine then rapidly into the active 6-monoacetylmorphine (6-MAM) and then into morphine which bind to the mu opioid receptors resulting in the drug’s euphoric effects. Codeine is not a metabolite of heroin. Golden Crescent is a term related to heroin trafficking. Heroin’s metabolites are full agonists to the opiate receptors and are short-acting. Withdrawal syndromes may begin 6 to 24 hours after discontinuing the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A 44-year-old man who has a past medical history of alcohol abuse develops chronic abdominal pain and starts taking his wife’s Percocet. He reads about “Kratom” on the internet and subsequently buys the “full spectrum tincture” of Kratom from the vendor and begins taking it as a substitution for the Percocet. He eventually increases the dose of Kratom to 6 “dropper squeezer” every 4 hours on a continuous basis and is unable to stop. He presents to your office with typical opiate-type withdrawal symptoms and the additional history that he has gained 60 pound s over the past year, has become lethargic, and he is edematous. The most likely explanation for this man’s clinical presentation is: A Congestive heart failure. B Chronic liver disease. C Primary hypothyroidism. D Chronic renal insufficiency. E Severe anemia.

A

Kratom is known as mitragyna speciosa korth and is a tropical tree indigenous to Thailand and other areas of South East Asia. Mitragynine, the major alkaloid identified from Kratom has been reported as a partial opioid agonist producing effects similar to morphine. Some indole alkaloids such as reserpine may primarily affect thyroid gland and cause primary hypothyroidism and Kratom is an indole alkaloid in high doses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many different types of opiate receptors have been identified in the human nervous system? A 2 B 3 C 4 D 5 E 6

A

Most of the clinically active opioids are active at the mu receptor. The other 3 receptors are kappa, delta, and ORLF, mediating both the analgesic and rewarding effects of opioid compounds as well as their effects on many systems in the body such as the hypothalamic-pituitary-adrenal (HPA) axis, immune, gastrointestinal (GI) and pulmonary function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following statements about naltrexone is true? A It is only available in parenteral form. B It has low receptor affinity. C It is poorly absorbed from the gut. D It has a short duration of action. E It prevents opiate agonists from binding to the receptor.

A

Naltrexone is a relatively pure antagonist in that it produces little or no agonist activity at usual doses and prevents opiate agonists from binding to the receptor and producing opiate effects. Naltrexone has high receptor affinity, and thus it can block virtually all the effects of the usual doses of opioids and opiates such as heroin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Methadone was developed in 1937 by scientists working for: A Adolph Hitler. B Marie Nyswander. C I.G. Farbenkonzern. D Professor Vincent Dole. E Eli Lilly and Company.

A

Methadone was developed when scientists at the Farbwerke Hoechst in 1937 under the direction of I.G. Farbenkonzern were looking for a synthetic opioid that could be created with readily available precursors to solve Germany’s opium shortage problem. Methadone was first manufactured in the USA by Eli Lilly and Company who first obtained FDA approval on August 14, 1947. Marie Nyswander and Professor Vincent Dole studied methadone substitution therapy successfully in the 1960’s and Adolph Hitler had no documented role in the development of methadone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A legislative act provided that physicians could prescribe narcotics to their patients “in the course of professional practice only.” A 1906 Pure Food and Drug Act. B 1914 Harrison Narcotic Tax Act. C 1961 Convention on Narcotics. D 1970 Controlled Substance Act. E 2000 Drug Addiction

A

The Harrison Narcotic Tax Act provided that physicians could prescribe narcotics to their patients in the course of their usual practice, but they could not use narcotics to treat opiate addiction because addiction was not recognized as a disease in 1914. The Pure Food and Drug Act did not address opiates specifically. The 1961 Convention on Narcotics addressed marijuana. The 2000 Drug Addiction Treatment Act provided that qualified physicians could utilize Schedule III, IV, and V drugs to treat opiate addiction and changed buprenorphine to Schedule III.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A 45-year-old female methadone clinic patient with a history of prior seizures, recent tuberculosis exposure and mild edema is brought in by her family in a lethargic state for evaluation. The patient had been stable on 80 mg per day of methadone for four months. The patient’s sister reports that she visited their family doctor recently and something was prescribed. Which of the following medications prescribed by the patient’s family doctor could be responsible for the patient’s lethargy? A Dilantin B Spironolactone C Ciprofloxacin D Acamprosate E Rifampin

A

Ciprofloxacin is a cytochrome P450 inhibitor. Administration will increase methadone levels. Dilantin, spironolactone and rifampin are cytochrome P450 inducers, and methadone levels will decrease. Thus, opiate withdrawal symptoms would be more likely. Acamprosate would likely have no effect on methadone metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the average dose necessary to achieve an optimal treatment outcome for a patient in a methadone maintenance program? A 30 mg/day. B 40 mg/day. C 50 mg/day. D 80 mg/day. E 140 mg/day.

A

Multiple studies have confirmed that methadone doses in the range of 60-120 mg/day lead to superior outcomes as compared to doses below this range. No evidence suggests that doses above 120 mg/day are consistently more beneficial with regard to outcome measures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

All of the following are true regarding opioid agonist maintenance therapy except A The effectiveness of methadone and other opioid agonist treatments for reducing morbidity, mortality, and social dysfunction has been validated by several meta-analytic studies. B Only about one-fifth of heroin-dependent individuals are enrolled in agonist maintenance treatment. C When methadone maintenance treatment has been made easily available at a low cost, and publicized, 90% or more heroin addicts have sought treatment. D Daily dosing of methadone above 100 mg per day should be avoided because it is dangerous and rarely helpful. E Patients who are provided minimal drug counseling have been shown to be at substantially increased risk of continued illicit drug use, despite adequate methadone dosing.

A

Although effective doses of methadone generally are between 60 and 100 mg daily, full attenuation of heroin effects may only be seen at higher doses, and should be optimized based on individual patient response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Methadone may be used effectively to assist in withdrawing a patient from opioids that are more addicting. However, this is only advised for certain opioids. Addiction to which of the following is not appropriately managed by using methadone substitution and eventual taper? A Pentazocine B Morphine C Hydromorphone D Oxycodone E Heroin

A

In general, a more addictive drug should not be used to detoxify a patient from a less addictive one. Although methadone can be used to withdraw patients from narcotics such as heroin, morphine, hydromorphone, oxycodone, or meperidine, it should be avoided for drugs such as propoxyphene or pentazocine, for which the withdrawal should be handled by gradually decreasing the dosage of the agent itself or by an agent such as clonidine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

There are a number of potential medication interactions with methadone. Which of the following medications may reduce plasma methadone levels? A Risperidone B Fluoxetine C Sertraline D Cimetidine E Fluvoxamine

A

Risperidone may reduce plasma methadone levels, while fluoxetine, sertraline, cimetidine, and fluvoxamine may increase them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nalmefene differs from naloxone primarily in which of the following ways? A Nalmefene is available in parenteral form. B Nalmefene is a pure agonist. C Nalmefene is available in an oral form. D Nalmefene has a much longer duration of action. E Nalmefene activates opiate receptors.

A

Nalmefene has a much longer duration of action than naloxone. Both nalmefene and naloxone are available in parenteral and oral form. They are antagonists and occupy opiate receptors but do not activate them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which of the following opioids should not be used in chronic pain patients with renal insufficiency? A Methadone B Hydromorphone C Butorphanol D Meperidine E Nalbuphine

A

Meperidine’s active metabolite, normeperidine, can rapidly accumulate in patients with renal disease and cause seizures. All other choices are opioids that can be used safely in patients with renal insufficiency.

17
Q

What is the safest starting dose of methadone in an inpatient setting to effectively suppress withdrawal in most patients?

A

The safest starting dose that will effectively suppress withdrawal in most patients is 10 to 20 mg. Doses at 5 mg are likely too low to suppress withdrawal. Doses close to or above 40 mg can potentially be fatal in patients who do not have adequate tolerance.

18
Q

A 45-year-old man with a history of heroin dependence who has been stable on methadone 70 mg p.o. daily for five years gets into a near-fatal car accident. He fractures his jaw and is unable to take any medication by mouth. What is the preferred way to manage his acute pain? A Convert the daily methadone dose to an equivalent dose of intravenous morphine sulfate and administer that dose. B Convert the daily methadone dose to an equivalent dose of intravenous morphine sulfate and administer one dose higher than that until the pain is controlled. C Convert the daily methadone dose to an equivalent dose of buprenorphine and administer that dose. D Give the equivalent dose of patient’s methadone in divided intramuscular doses and then administer higher than normal doses of short-acting parenteral opioids to achieve pain control. E All of the above are preferred options.

A

Because of the cross-tolerance to methadone, the patient’s baseline methadone dose can be maintained by giving intramuscular methadone in divided doses and then treating the acute pain with higher than normal doses of short-acting opioids. Option B is a possibility, but would not be an optimal choice because it would disrupt the steady-state plasma level of methadone and patient would then have to be reintroduced to methadone after the pain crisis has resolved. Giving the equivalent dose would not likely treat the acute pain syndrome (Option A), and giving a partial agonist/antagonist such as buprenorphine, could precipitate opioid withdrawal (Option C).

19
Q

The negative reinforcement theory of opioid dependence postulates an overload of which of the following in the neural system of the addict, leading to continued abuse of opioid substances? A Deficit B Instability C Excessive dopamine. D Hyperexcitability E Allostasis

A

The negative reinforcement model sees addiction as an example of allostatis overload, in which a biological system fails to maintain a homeostatic balance leading to a state characterized by an abnormal set point. This model sees brain reward and stress response systems as being out of balance. The stress response system is too sensitive, whereas the reward system is not sensitive enough. Ingestion of the opioid drug temporarily moves the system closer to homeostasis

20
Q

Which of the following is not a difference between methadone and naltrexone? A Methadone is an effective treatment for the severe heroin-dependent patient, whereas naltrexone is not. B Unlike methadone, naltrexone cannot be given until all opioids have been cleared from the body. C Unlike methadone, naltrexone has no intrinsic opioidergic properties. D Unlike naltrexone, methadone does not block the effects of opioids E Unlike methadone, naltrexone does not produce a physical dependence syndrome

A

Option A is correct because both methadone and naltrexone are treatments for heroin-dependent patients, irrespective of severity. Although many severe heroin addicts will prefer methadone over naltrexone, naltrexone is still a viable, important option for them.

21
Q

All of the following are true regarding the use of naltrexone except: A If the naloxone challenge test is negative, naltrexone can be started at a 25 mg dose B The usual daily dose is 50 mg by mouth daily. C Observing the ingestion of naltrexone is not an essential part of treatment for opioid dependence. D After one to two weeks, it is possible to give naltrexone three times per week.

A

Naltrexone is a useful treatment but compliance in taking it is often a problem in the opioid-dependent patient population. Therefore, most practitioners recommend observed or monitored pill ingestion. The initial dose is 25 mg after the naloxone challenge (Option A), the usual dose is 50 mg (Option B), and the drug can be eventually given three times per week because of its long half-life (Option D).

22
Q

What is the half life of methadone

A

Methadone’s elimination half-life (8-59 hours) is longer than its duration of analgesic action (4-8 hours).

23
Q

What forms does methadone exist?

A

Exists as l and d forms. The d form is an NMDA receptor antagonist

24
Q

Highly tolerant opioid users, maintained on their drug in a research setting, will: A Continue to feel a “rush” when their drug of choice is administered intravenously. B Continue to use their drug of choice for reasons other than fear of experiencing withdrawal. C Continue to experience pleasurable effects from food, sex, tobacco and other non-opiate drugs. D All of the above.

A

D All of the above.

25
Q

The psychoactive properties of opioids reported among populations of addicts include each of the following EXCEPT: A Anxiolytic or tranquilizing action B Reduction of rage and aggression C Increased libido and sexual arousal D Reduction of paranoia and ideas of reference E Relief of symptoms of depression and reduced suicidal ideation

A

C. Increased libido and sexual arousal

26
Q

A 25-year-old heroin addict, taking oral methadone, delivered an infant who had difficulty breathing. After 0.2 mg naloxone (Narcan), the baby went into generalized convulsions. To terminate the seizures, which of the following should be administered? A Diazepam (Valium). B Morphine C Naloxone (Narcan). D Paraldehyde E Phenobarbital

A

B Morphine

27
Q

A 22-year-old woman presents for admission to a methadone maintenance pro-gram. Which of the following would be the best indicator of current heroin dependence? A A positive history corroborated by acquaintances or relatives of the patient. (Your Answer) B The presence of needle marks and/or phlebitic scars. C A positive urine screening for heroin. D Development of the opioid withdrawal syndrome. E Marked miosis produced by an intra- venous dose of morphine (10 mg).

A

D Development of the opioid withdrawal syndrome.

28
Q

Among chronic users, withdrawal symptoms can be found with all of the following drugs EXCEPT: A Meperidine (Demerol). B Ethanol C Barbiturates D Thioridazine (Mellaril). E Meprobamate (Equanil).

A

D Thioridazine (Mellaril).

29
Q

Which of the following opioids should NOTbe used in chronic pain patients with renal isnsufficiency? A Methadone B Hydromorphone C Butorphanol D Meperadine E Nalbuphine

A

Meperadine’s active metabolite, normeperidine, can rapidly accumulate in patients with renal disease and cause seizures.

30
Q

A standard order for Meperidine (Demerol) 75 mg every four hours following hip fracture surgery is inappropriate because: A Effective analgesia lasts only 2.5 to 3 hours. B If a person is also receiving a MAOI severe toxicity can occur. C There is an increased risk for delirium compared to other opioids. D in the presence of impaired renal function, toxicity may occur. E All of the avbove.

A

E All of the above